Urologic Pathology in 2017: Emerging Concepts,
WHO Classification and AJCC Updated
May 19 - 21, 2017
Physicians Can Earn A Maximum Of 17.5 AMA PRA Category 1 Credits™
Physicians Can Earn A Maximum Of 13.5 SAM Credit Hours
Donna E. Hansel, M.D., Ph.D.
Dr. Donna Hansel was born in Minneapolis, MN, and moved to Florida at the age of 5. She completed her primary and secondary education in South Florida. She subsequently enrolled in the Bachelor of Science degree program in Biology at the Johns Hopkins University, graduating Phi Beta Kappa. During her undergraduate career, Dr. Hansel was actively engaged in numerous academic activities that included laboratory research, with her first presentation at the Society for Neuroscience during her sophomore year. She was accepted into the M.D., Ph.D. Medical Scientist Training Program at the Johns Hopkins School of Medicine, where she completed her Ph.D. in the Neurosciences, with first author publications in the Journal of Neuroscience and Nature. She was awarded a Multiple Sclerosis Society Fellowship in 2001 to study dorsal root ganglia biology in the Genetics and Pathology Departments at the Erasmus University in Rotterdam, the Netherlands. She returned to the Johns Hopkins School of Medicine at the end of her fellowship, where she completed her residency in Anatomic Pathology and a genitourinary pathology fellowship with Dr. Jonathan Epstein in 2006. Dr. Hansel was awarded membership into Alpha Omega Alpha at the completion of her residency.
Dr. Hansel joined the Cleveland Clinic Anatomic Pathology Staff led by Dr. John Goldblum in 2006 as a subspecialty genitourinary pathologist, and was appointed as an Assistant Professor of Anatomic Pathology at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, with joint appointments in the Case Comprehensive Cancer Center, Genomic Medicine Institute, Taussig Cancer Center, and Glickman Urological and Kidney Institute. Dr. Hansel continued to expand her research focus in bladder cancer, given her passion to develop new diagnostic and therapeutic interventions for patients with this historically understudied disease. She received funding during this time from the National Institutes of Health and the American Cancer Society to study the role of mTOR complex function in bladder cancer cell invasion, and advanced to the rank of Associate Professor. Dr. Hansel also oversaw the prospective multi-institutional collection of bladder cancer specimens for the Cancer Genome Atlas Project during this time, and continues to support the mission of this enterprise. In 2013, she was recruited to the University of California at San Diego as a Professor of Pathology with Tenure and Chief of the Division of Anatomic Pathology by Dr. Steven Gonias. She oversees an interdisciplinary research program in bladder cancer that incorporates advanced –OMICs technologies in the analysis of human bladder cancers, identifying cell signaling pathways that may be targets for bladder cancer therapeutics development in the future. Dr. Hansel has also implemented a highly subspecialized Division focus and continues to grow the outstanding group of Anatomic Pathology faculty at this institution. She is honored to be the recipient of the 2016 Ramzi S. Cotran Young Investigator Award.
Dr. Hansel has authored over 100 peer-reviewed publications, edited or authored 5 textbooks on urologic pathology and biospecimen repositories, and has participated in more than 50 national or international talks on bladder cancer. She has participated in the Kidney-Urinary tract panel for the 8th Edition of the AJCC Cancer Staging Manual and contributed to the upcoming 4th edition of the WHO Classification of Tumours of the Urinary System and Male Genital Organs. She is currently on the Editorial Board for Advances in Anatomic Pathology and is a section editor for urologic oncology in Archives of Pathology and Laboratory Medicine and has mentored over 20 residents, graduate students and postdoctoral fellows, while remaining active in clinical service. She remains grateful to all those who have mentored her along her career path, as well as to former and current collaborators - all of whom have challenged her to grow and think in new ways about clinical diagnostics and laboratory research.
Dr. Hansel was the 2016 recipient of the coveted Ramzi S. Cotran Young Investigator’s Award.
John Cheville, M.D.
John Cheville, M.D. is a surgical pathologist and Professor of Pathology at the Mayo Clinic. He is the Director of Biomarker Discovery in the Center of Individualized Medicine at Mayo with a primary interest in urologic malignancies.
Michelle S. Hirsch, M.D., Ph.D.
Dr. Hirsch completed graduate and medical schools at Boston University School of Medicine. Her residency program in Anatomic Pathology at the Brigham and Women’s Hospital included the Chief Resident position, followed by fellowship training in Genitourinary (GU) and Women’s and Perinatal (W&P) Pathology. She was subsequently hired as a Staff Pathologist at BWH where she currently works. For ten years Dr. Hirsch served as Associate Director for the Women’s and Perinatal Pathology Fellowship program, she has been the Chief of the Genitourinary Pathology Service since 2010, and she was promoted to Associate Professor of Pathology at Harvard Medical School in 2012. Her overall responsibilities span diagnostic surgical pathology, translational research, and teaching. She is considered an expert in GU and W&P pathology with emphases on renal and ovarian tumor pathology and biomarkers. She has developed 3 clinically annotated tissue microarrays for ovarian, endometrial and renal carcinoma, resulting in presentations at many scientific meetings as well as multiple scientific publications in prestigious journals. In 2105, Dr. Hirsch edited the GU edition of Surgical Pathology Clinics, and was a faculty member for the USCAP interactive course in St. Louis, MO. Currently Dr. Hirsch is a member of the USCAP Education Committee, faculty for a USCAP Short Course, and serves as President Emeritus for the New England Society of Pathologists. She is proud to be a mentor for pathologists-in-training whose career paths have been enhanced by her influence.
Peter A. Humphrey, M.D., Ph.D.
Dr. Humphrey is Professor of Pathology and Director of Genitourinary Pathology at Yale University School of Medicine. He is a practicing surgical and urologic pathologist at Yale New-Haven Hospital in Connecticut. He has published over 300 papers, has authored the textbook Prostate Pathology, co-authored the textbook Gleason Grading of Prostate Cancer, co-authored the AFIP Fascicle on the Prostate, co-authored the textbook Neoplastic Mimics in Genitourinary Pathology, is co-editor of The Washington Manual of Surgical Pathology, and is a volume editor for 2016 WHO GU tumor classification book. He is past President of the International Society of Urological Pathology and is now President of The Arthur Purdy Stout Society of Surgical Pathologists. He has given lectures on 6 of the 7 continents (with only Antarctica to go). He has long-standing interests in urologic pathology and oncology in general, with a specific focus on prostatic diseases and prostate cancer. Dr. Humphrey holds the honor of presenting the prestigious Maude Abbott Lecture at the 2017 Annual Meeting of the United States and Canadian Academy of Pathology.
Karim A. Kader, M.D., Ph.D.
Dr. Kader is one of the most experienced surgeons in the United States performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer. He received his undergraduate, doctorate of philosophy, and medical degrees from the University of British Columbia and completed his urology residency at the University of Toronto. He completed a urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Kader holds several patents for genetic discoveries and medical devices that hold significant promise for enhancing the care of patients at risk for end with urologic malignancies. He is the principal investigator for numerous clinical research trials and has published extensively. His research interests include genetic markers of risk and outcome in urologic cancer.
John R. Srigley, M.D., FRCPC, FRCPath, FRCPA [Hon.]
Dr. Srigley is a graduate of the Faculty of Medicine, University of Toronto, who undertook postgraduate training in anatomic and oncologic pathology at the University of Toronto and MD Anderson Cancer Center in Houston, Texas. Dr. Srigley has practiced surgical and urologic pathology for over 30 years and is currently the Chief and Medical Director of the Program of Laboratory Medicine and Genetics at Trillium Health Partners, one of the largest community-academic hospitals in Canada. He is also a Professor in the Department of Pathology and Molecular Medicine at McMaster University. Dr. Srigley is an international consultant and educator in surgical and urologic pathology and has contributed extensively to the literature. He is an editor/author of three textbooks on urological pathology including the series 3 AFIP Fascicle on Tumors of the Prostate Gland. Dr. Srigley has been an author and member of the international working groups for the 2004 and 2016 WHO Bluebooks on Tumors of the Urinary System and Male Genital Organs. He is the Canadian representative on the American Joint Committee on Cancer and a member of the AJCC male genital system expert panel. He is a Past President of the International Society of Urological Pathologists (ISUP) and the Ontario Association of Pathologists. His research interests include clinical-pathological and translational studies of urological cancer, population-level quality initiatives in cancer pathology and the role of the pathologist in cancer control. Dr. Srigley is also a founding board member of the International Collaboration on Cancer Reporting (ICCR) and has provided advice on population-level standardized cancer pathology reporting to the College of American Pathologists as well as groups in Australasia, Poland, Norway and Brazil.